Molecular dynamics of human-specific cytolysin: Analysis of membrane binding motif for therapeutic application

Anticancer Research

Volumn 26, Issue 6 A, 2006, Pages 4055-4062

  Ohkura, Kazuto ^a   Hori, Hitoshi ^b   Nagamune, Hideaki ^b  

^a NAGOYA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Cholesterol; Cytolysin; Intermedilysin

Indexed keywords

CHOLESTEROL; CYTOLYSIN; INTERMEDILYSIN; MUTANT PROTEIN; STREPTOLYSIN O; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DIPOLE; ELECTRIC POTENTIAL; HEMOLYSIS; HYDROPHOBICITY; MEMBRANE BINDING; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; SOLVATION; STREPTOCOCCUS INTERMEDIUS;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; BACTERIOCINS; CELL MEMBRANE; COMPUTER SIMULATION; ELECTROSTATICS; ERYTHROCYTES; HEMOLYSIS; HORSES; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; RABBITS; SEQUENCE ALIGNMENT; SHEEP; STREPTOLYSINS; THERMODYNAMICS;

EID: 33845923346     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Nagamune H, Ohkura K, Sukeno A, Cowan G, Mitchell TJ, Ito W, Ohnishi O, Hattori K, Yamato M, Hirota K, Miyake Y, Maeda T and Kourai H: The human-specific action of intermedilysin, a homologue of streptolysin O, is dictated by domain 4 of the protein. Microbiol Immunol 48: 677-692, 2004.
2. Ohkura K, Nagamune H and Kourai H: Structural analysis of human specific cytolysin intermedilysin aiming application to cancer immunotherapy. Anticancer Res 24: 3343-3354, 2004.
3. Billington SJ, Jost BH and Songer JG: Thiol-activated cytolysins: structure, function and role in pathogenesis. FEMS Microbiol Lett 182: 197-205, 2000.
4. Olofsson A, Herbert H and Thelestam M: The projection structure of perfringolysin-O (Clostridium perfringens thetatoxin). FEBS Lett 379: 125-127, 1993.
5. Korchev YE, Bashford CL, Pederzolli C, Pasternak CA, Morgan PJ, Andrew PW and Mitchell TJ: A conserved tryptophan in pneumolysin is a determinant of the characteristics of channels formed by pneumolysin in cells and planar lipid bilayers. Biochem J 329: 571-577, 1998.
6. Sekino-Suzuki N, Nakamura M, Mitsui K and O-Iwashita Y: Contribution of individual tryptophan residues to the structure and activity of θ-toxin (perfringolysin O), a cholesterol-binding cytolysin. Eur J Biochem 241: 941-947, 1996.
7. Jones S, Preiter K and Portnoy D: Conversion of an extracellular cytolysin into a phagosome-specific lysin which supports the growth of an intracellular pathogen. Mol Microbiol 21: 1219-1225, 1996.
8. Nagamune H, Ohnishi C, Katsuura A, Fushitani K, Whiley RA, Tsuji A and Matsuda Y: Intermedilysin, a novel cytotoxin specific for human cells, secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess. Infect Immun 64: 3093-3100, 1996.
9. Ohkura K and Hori H: Analysis of structure-permeability correlation of nitrophenol analogues in newborn rat abdominal skin using semiempirical molecular orbital calculation. Bioorg Med Chem 7: 309-314, 1999.
10. Ohkura K, Sukeno A, Yamamoto K, Nagamune H, Maeda T and Kourai H: Analysis of structural features of bis-quaternary ammonium antimicrobial agents 4,4′-(α,ω-Polymethylenedithio) bis(1-alkylpyridinium iodide)s using computational simulation. Bioorg Med Chem 11: 5035-5043, 2003.
11. Jin CZ, Nagasawa H, Shimamura M, Uto Y, Inayama S, Takeuchi Y, Kirk KL and Hori H: Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers. Bioorg Med Chem 12: 4917-4927, 2004.